Skip to main content
Clinical Trials/IRCT2013012610817N3
IRCT2013012610817N3
Completed
未知

Pharmacokinetic of intamuscular and intravenous methadone in critically ill patients

Tehran University of Medical Siences0 sites40 target enrollmentStarted: TBDLast updated:

Overview

Phase
未知
Status
Completed
Sponsor
Tehran University of Medical Siences
Enrollment
40

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 65 years (—)
Sex
All

Inclusion Criteria

  • Inclusion criterion: critically ill patients in ICU, who require pain management with opioids.
  • Exclusion criteria: hypersensitivity to methadone or any component of the formulation; patients older than 65 years old; patients with renal failure( Scr \> 2mg/dl ,Urine Output \<0\.5cc/kg/hour) 4\. ); patients with hepatic failure(hepatic enzymes more than 3 times normal); patients with Platelet less than 100000; mean arterial pressure less than 65 or who require inotrope or vasopressor and patient who suffer ALI (PaO2 /FIO2\<300\).

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Tehran University of Medical Siences

Similar Trials

Active, not recruiting
Phase 1
Absorption and excretion of melatonin when applied intravenously, rectally, in the bladder, vaginally and dermally in healthy female volunteers
EUCTR2017-000997-13-DKCenter for Perioperative Optimization, Department of Surgery, Herlev Hospital10
Completed
Phase 1
Pharmacokinetics of intralesional EGF in patients with diabetic foot ulcers.Diabetic foot ulcer, Wagner grades 1 or 2Diabetic FootFoot UlcerLeg UlcerSkin UlcerDiabetic AngiopathiesVascular DiseasesDiabetes ComplicationsDiabetic NeuropathiesDiabetes MellitusEndocrine System DiseasesCardiovascular Diseases
RPCEC00000047Center for Genetic Engineering and Biotechnology (CIGB), Havana.16
Active, not recruiting
Phase 1
Pharmacokinetics of intraperitoneal and intravenous fosfomycin in automated peritoneal dialysis patients without peritonitisA total of 8 patients with renal insufficiency and treatment with automated peritoneal dialysis (APD) will be enrolled into this study evaluating the pharmacokinetics of fosfomycin in this special patient group.MedDRA version: 9.1Level: LLTClassification code 10034660Term: Peritoneal dialysis
EUCTR2009-011505-16-ATMedizinische Universität Wien,KIM I,Klinische Abteilung für Infektionen u.Tropenmedizin8
Completed
Not Applicable
Assessing blood levels of ketorolac ( Toradol) injected in around the hip and knee joints in patients undergoing joint replacements
ACTRN12613000923763Dr.Usha Gurunathan18
Recruiting
Phase 1
Pharmacokinetics of the Intralesional administration of rhEGF (doses: 75 µg and 225 µg) in advance Diabetic Foot UlcersDeep Ischemic Diabetic Foot Ulcers that reach joint capsule and bone, with or not bone exposition, without osteomyelitis and infection.
RPCEC00000148Center for Genetic Engineering and Biotechnology (CIGB)25